Dog Cancer Therapeutics Market Research Report – Segmentation by Cancer Type (Lymphoma, Mast Cell Tumours, Melanoma, Neoplasm, and Others); By Treatment Type (Chemotherapy, Radiation Therapy, Immuno Therapy, and Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15219
Format:
Region: Global
Chapter 1. DOG CANCER THERAPEUTICS MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. DOG CANCER THERAPEUTICS MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. DOG CANCER THERAPEUTICS MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. DOG CANCER THERAPEUTICS MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. DOG CANCER THERAPEUTICS MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. DOG CANCER THERAPEUTICS MARKET – By Cancer Type
6.1 Lymphoma
6.2. Mast Cell Tumours
6.3. Melanoma
6.4. Neoplasm
6.5. Others
Chapter 7. DOG CANCER THERAPEUTICS MARKET– By Treatment Type
7.1 Chemotherapy
7.2. Radiation Therapy
7.3. ImmunoTherapy
7.4. Others
Chapter 8. DOG CANCER THERAPEUTICS MARKET – By Region
8.1. North America
8.2. Europe
8.3.The Asia Pacific
8.4.Latin America
8.5. Middle-East and Africa
Chapter 9. DOG CANCER THERAPEUTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1. Aratana Therapeutics
9.2. Vetivax
9.3. Regeneus
9.4. Zoetis
9.5. Torigen Pharmaceuticals
9.6. Qbiotics
9.7. ELIAS Animal Health
9.8. NovaVive
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Global Dog Cancer Therapeutics Market was estimated to be worth USD 200 million in 2022 and is anticipated to reach a value of USD 295.49 million by 2030, growing at a fast CAGR of 5% during the forecast period 2023-2030.
Advancements in veterinarian treatments and increasing incidence of cancer in dogs are the market drivers for Global Dog Cancer Therapeutics Market
Lymphoma, Mast Cell Tumours, Melanoma, Neoplasm, and Others are the segments under the Global Dog Cancer Therapeutics Market by cancer type
North American region dominates the market for Global Dog Cancer Therapeutics
Asia-Pacific is the fastest-growing region in the Global Dog Cancer Therapeutics Market
